Genetic or pharmacologic Nrf2 activation increases proteinuria in chronic kidney disease in mice-Reference-Cited by-同舟云学术

Genetic or pharmacologic Nrf2 activation increases proteinuria in chronic kidney disease in mice

Published:2021-01 Issue:1 Volume:99 Page:102-116
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Rush Brittney M.,Bondi Corry D.,Stocker Sean D.,Barry Kacie M.,Small Sarah A.,Ong Jason,Jobbagy Soma,Stolz Donna B.,Bastacky Sheldon I.,Chartoumpekis Dionysios V.,Kensler Thomas W.,Tan Roderick J.

Funder

National Institutes of Health

American Society of Nephrology

National Kidney Foundation

American Heart Association

Publisher

Elsevier BV

Subject

Nephrology

Reference55 articles.

1. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD;Inker;Am J Kidney Dis,2014

2. Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy;Johnson;Am J Physiol Renal Physiol,2015

3. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group;Lewis;N Engl J Med,1993

4. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis;Yamamoto;Physiol Rev,2018

5. Value of monitoring Nrf2 activity for the detection of chemical and oxidative stress;Mutter;Biochem Soc Trans,2015

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of a drug, miRNA, and transcription factor regulatory network in membranous nephropathy based on oxidative stress-related genes;Journal of Taibah University for Science;2024-06-26

2. The redox-sensitive GSK3β is a key regulator of glomerular podocyte injury in type 2 diabetic kidney disease;Redox Biology;2024-06

3. Autocatalytic, Brain Tumor‐Targeting Delivery of Bardoxolone Methyl Self‐Assembled Nanoparticles for Glioblastoma Treatment;Small Science;2024-05-22

4. Podocyte-Specific Deletion of MCP-1 Fails to Protect against Angiotensin II- or Adriamycin-Induced Glomerular Disease;International Journal of Molecular Sciences;2024-05-03

5. NRF2 in kidney physiology and disease;Physiological Reports;2024-02-28